39x™️ PATCHES & OTHER PATENTS
X39 REASERCH & PAPERS
List of Services
-
Fast Facts on X39™️ Research • 17 Amino acid changes at significance at the end of the week.Fast Facts on X39™️ Research
• Produced anti-inflammatory e ects based on amino acid results.
• A reduction in blood pressure at significance.
• Improves quality of sleep.
• Increased vitality.
• Improved short term memory. -
Phototherapy Induced Metabolism Purpose: To determine X-39 patch impact in stimulation of Copper peptide biosynthesis and bio-available amino acid levels, neurotransmitters production, memory, sleep quality, vitality, muscle relaxation and blood pressure.Phototherapy Induced Metabolism
Summary: The results of the double blind randomized controlled trial of 50 subjects using the LifeWave non-transdermal X-39 phototherapy patch produced an increase in 8 amino acids at significant levels. The Research showed there was an improvement in short term memory at significant levels over 7 days, in quality of sleep at significant levels within 24 hours and a self-reported increase in vitality at near significant levels in 7 days. The findings suggest this patch is not only stimulating the biosynthesis of copper-peptide production, but also increases neurotransmitters production and improves metabolism.
— Melinda H. Connor, DD, PhD, AMP, FAM
— Caitlin A. Connor, MAcOM, DAOM
— Naran Gombusuren, PhD
— Jens Eickhoff, PhD
— Nathan Anderson, MACOM, LAc
— Marsha Perry, RN, MA
— Leonard Peugh, MAcOM -
Double-Blind Testing of the Lifewave X39 Patch to Determine GHK-Cu Production Levels Internal Medicine Research - Open Journal (Volume 6(1): 1-3)Double-Blind Testing of the Lifewave X39 Patch to Determine GHK-Cu Production Levels
Purpose: To determine if the LifeWave X39 non-transdermal photobiomodulation active patch would show improved production of GHK-Cu over controls in a double blind randomized controlled trial.
This highly anticipated Research was designed to test the impact of wearing X39® patches on the levels of GHK-Cu levels in the blood over the period of one week. The results of the trial demonstrate that X39 elevates GHK and GHK-Cu peptides by about 40% within seven days, as compared to placebo which experiences no changes.
— Caitlin A. Connor, MAcOM, DAOM
— Melinda H. Connor, DD, PhD, AMP, FAM
— David Yue, PhD, Chiu-An Chang, DO
— DO,Lac, Jens Eickhoff, PhD
— Susan Wagner, DAOM, LAc, BCIM
— Amy Chang, PhD -
Changes in Tripeptides Produced By the LifeWave X39 Patch International Journal of Healing and Caring (Vol 20, Issue 2, May 2020)Changes in Tripeptides Produced By the LifeWave X39 Patch
Purpose: To determine if the LifeWave X39 non-transdermal patch can produce changes in tripeptides GHK and GHK-Cu production.
— Caitlin A. Connor, MAcOM, DAOM
— Melinda H. Connor, DD, PhD, AMP, FAM
— David Yue, PhD, Chiu-An Chang, DO
— DO,Lac, Jens Eickhoff, PhD
— Susan Wagner, DAOM, LAc, BCIM
— Amy Chang, PhD -
LifeWave X39 Pilot Demonstrates Light Triggered Changes International Journal of Healing and Caring (Vol 20, Issue 2, May 2020)LifeWave X39 Pilot Demonstrates Light Triggered Changes
Purpose - To determine if metabolic and physiological changes were produced by participants wearing the LifeWave non-transdermal X39 phototherapy patch.
— Melinda H. Connor, DD, PhD, AMP, FAM
— Caitlin A. Connor, MAcOM, DAOM
— Naran Gombosuren, PhD
— Jens Eickhoff, PhD
— Leonard Pugh, MAcOM -
Experimental Research of Lifewave X-39™ Patches (November, 2018) The Centre for Biofeld SciencesExperimental Research of Lifewave X-39™ Patches (November, 2018)
— Dr. Thornton Streeter
— Dr. Rachana Shetty
— Shesh Iyer
— Harshitha
— Mohan Kumar -
Research by Gaetan Chevalier, Ph.D., Research Director for Psy-Tek Labs (January 2020) Dr. Gaetan Chevalier completed this Research of LifeWave X39® patches in December 2019. He concluded that the X39® patch is dramatically effective in improving brain function. This Research includes stunning before-and-after brain-mapping visuals.Research by Gaetan Chevalier, Ph.D., Research Director for Psy-Tek Labs (January 2020)
-
Osteoarthritis Double-Blind Placebo Controlled IceWave Pain Relief Research (June 2013) PharmaScanOsteoarthritis Double-Blind Placebo Controlled IceWave Pain Relief Research (June 2013)
— Dr. Pierre Volckmann -
A double-blind placebo-controlled heart rate variability investigation to evaluate the quantitative effects of the organic nanoscale aeon patch on the autonomic nervous system. TANG International Journal of Genuine Traditional Medicine (Vol 5, Issue 1, Feb 2015)A double-blind placebo-controlled heart rate variability investigation to evaluate the quantitative effects of the organic nanoscale aeon patch on the autonomic nervous system.
— Homer Nazeran PhD, CPEng (Biomed.)
Department of Electrical and Computer Engineering and Biomedical Engineering Graduate Programs University of Texas at El Paso, USA -
Effects of energy enhancer patches on cortisol production, peripheral circulation, and psychological measures: a pilot Research. Advances in Mind-body Medicine · January 2015Effects of energy enhancer patches on cortisol production, peripheral circulation, and psychological measures: a pilot Research.
— Melinda H. Connor, D.D., Ph.D., AMP, FAM. (Akamai University, Hilo, Hawaii)
— Ann Baldwin (The University of Arizona) -
Effect of IceWave®; organic nanoscale patches on reduction of musculoskeletal pain TANG International Journal of Genuine Traditional Medicine (Vol 3, Issue 1, Feb 2013)Effect of IceWave®; organic nanoscale patches on reduction of musculoskeletal pain
— Emily Piven1,*, Rupesh Dharia2, Karen Jones3, Chuck Davis4, Homer Nazeran5
1Health Matters of Florida, Oakland, Florida 34760 USA; 2Palm Beach Internal Medicine, Palm Beach, Florida 33410 USA; 3Flagler Medical Associates, West Palm Beach, Florida 33401 USA; 4CSD Biostatistics Inc., San Diego, California 92130 USA; 5Electrical and Computer Engineering, University of Texas at El Paso, El Paso Texas 79968, USA -
Y-Age Glutathione US Patent 9149451Y-Age Glutathione
-
Y-Age Glutathione US Patent 8602961Y-Age Glutathione
-
Patch Technology US Patent 8734316Patch Technology
-
Mild stimulation of stomach 36 acupuncture point by organic nanoscale SP6 patch improves cellular physiologic functional status of different organs TANG International Journal of Genuine Traditional Medicine (Vol 2, Issue 1, Feb 2012)Mild stimulation of stomach 36 acupuncture point by organic nanoscale SP6 patch improves cellular physiologic functional status of different organs
— Homer Nazeran PhD, CPEng (Biomed.)
— Sherry Blake-Greenberg ND, MA, HMD
— Emily Haltiwanger OTD, MHE, OTR -
X39™️ US Patent 10716953X39™️
Ready To Try Our Patches?
MONEY BACK GUARANTEE
You read the research. Now, experience the healing power of LifeWave X39®—what many doctors, naturopaths and health care practitioners are calling one of the most important products of our lifetime.
An Independent LifeWave Distributor/Member
Read WHat Researchers are doing,
Experience The Healing Power
Disclaimer: Our patches are based on the theory of phototherapy. The patches are not proven based on conventional medicine standards and should not be used in place of medical care.